Pan-genomic And Multi-gene Panel Testing Market, By Test (Oncology Multi-Gene Panels, Pan-Genomic / Whole Exome Based Panels, Pharmacogenomics (PGx) Panels, and Comprehensive Hereditary Disease Panels), By Application, By End-use, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4647
|
Published Date
January 2026
|
Pages
344
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Pan-genomic And Multi-gene Panel Testing Market size was valued at US$ 8,907.34 Million in 2024, expanding at a CAGR of 12.04% from 2025 to 2032.
Pan-genomic and multi-gene panel testing represent advanced molecular diagnostic techniques designed to identify genetic variations associated with a wide range of diseases. Pan-genomic testing analyzes the entire genome or large genomic regions to detect diverse mutations, structural variations, and biomarkers, providing a comprehensive understanding of disease mechanisms and supporting personalized treatment strategies. In contrast, multi-gene panel testing targets a specific set of genes associated with particular conditions, offering a more focused, cost-effective, and faster diagnostic approach.
The adoption of these testing methods is being driven by the rising demand for precision medicine, early disease detection, and oncology diagnostics. Advances in next-generation sequencing (NGS) technologies, bioinformatics, and artificial intelligence are further improving the speed, accuracy, and interpretability of test results. For example, AI-driven algorithms can streamline variant classification and support clinical decision-making, making diagnostics more efficient and actionable.
Global healthcare trends highlight the growing impact of these tests: according to recent data, the global genomics market was valued at over $25 billion in 2024, with an expected CAGR of around 12% through 2030. The United States accounts for the largest share, driven by advanced healthcare infrastructure, high adoption of molecular diagnostics, and extensive R&D investments, while Asia Pacific is emerging as a high-growth region due to increasing healthcare access, government genomics initiatives, and growing oncology incidence in countries like China, India, and Japan. Despite these opportunities, the widespread adoption of pan-genomic and multi-gene panel testing faces challenges, including high costs, data complexity, regulatory hurdles, and limited clinical validation in certain settings. Ongoing improvements in sequencing efficiency, data analytics, and clinical integration are expected to address these barriers, expanding the global impact of these advanced diagnostic approaches in personalized healthcare.
Pan-genomic And Multi-gene Panel Testing Market- Market Dynamics
Rising Adoption of Precision Medicine
Precision Medicine is a personalized healthcare approach that tailors prevention, diagnosis, and treatment strategies based on an individual’s genetic profile, lifestyle, and environmental factors. By analyzing genetic variations, precision medicine provides insights into disease behavior and therapy responses, enabling more accurate and effective medical decisions. This approach reduces reliance on generalized treatments and enhances patient-specific outcomes. The growth of precision medicine is closely linked to the increasing use of pan-genomic and multi-gene panel testing, which allow simultaneous analysis of multiple genes to identify actionable variants, assess disease susceptibility, and guide tailored therapies. As adoption of precision medicine expands globally, demand for comprehensive genomic testing continues to rise. For example, in 2024, the NHS Genomic Medicine Service in England conducted over 810,000 genomic tests—a growth of 8% compared to 2023—demonstrating strong government support and increasing utilization of genomic testing for individualized patient care.
Pan-genomic And Multi-gene Panel Testing Market- Segmentation Analysis:
The Global Pan-genomic And Multi-gene Panel Testing Market is segmented on the basis of Test, Application, End-use, and Region.
By Test Type:
The Oncology Multi-Gene Panels segment accounts for a significant portion of the genetic testing market, driven by the high and rising prevalence of cancer globally. Cancer prevalence, which measures the total number of individuals living with cancer at a given time, is a key indicator for healthcare systems to plan resources, allocate treatments, and implement preventive measures. Multi-gene panels are essential in oncology because they enable clinicians to identify multiple genetic mutations that influence cancer development, progression, and response to treatment. This facilitates personalized therapies, targeted interventions, and improved patient outcomes. For example, as of January 2025, the American Cancer Society and the U.S. National Cancer Institute reported approximately 18.6million cancer survivors in the United States, about 5.4% of the population, a figure projected to exceed 22million by 2035. Globally, governments are prioritizing cancer control and precision medicine, with over 120 countries implementing national cancer control plans that promote early detection, genetic testing, and access to advanced diagnostics, directly supporting the adoption of oncology multi-gene panels.
By Application:
The oncology application segment dominates the market due to the rapid expansion of immunotherapies, which harness the body’s immune system to detect and eliminate cancer cells. These treatments, including immune checkpoint inhibitors, monoclonal antibodies, cancer vaccines, and adoptive cell therapies, rely heavily on genetic and molecular profiling to identify suitable patients, making oncology diagnostics such as multi-gene panels indispensable for personalized therapy. The increasing number of FDA-approved immunotherapies — over 150 agents, including 17 new approvals in 2024 — for more than 20 types of solid and hematologic tumors underscores the growing reliance on immune-based treatments. Globally, government health agencies and public research institutions are investing in precision oncology initiatives, with many countries allocating substantial budgets to immunotherapy research, cancer registries, and genomic testing infrastructure. For instance, international health authorities estimate that over USD12billion is invested annually worldwide in cancer research and precision medicine programs, reflecting the integration of multi-gene panels into standard oncology care and fueling market growth.
Pan-genomic And Multi-gene Panel Testing Market- Geographical Insights
The Pan-genomic and Multi-gene Panel Testing Market exhibits significant regional variation, influenced by healthcare infrastructure, technological adoption, and investments in precision medicine. North America continues to dominate the market, supported by advanced healthcare systems, high incidence of genetic disorders and cancers, widespread adoption of personalized medicine, and extensive genomic research initiatives. In Europe, the market is experiencing steady growth due to government support for precision medicine, favorable reimbursement policies, and growing awareness of genetic testing for early detection and targeted treatment.
The Asia Pacific region is emerging as a high-growth market, driven by rising healthcare expenditure, increasing prevalence of genetic and lifestyle-related diseases, and expansion of molecular diagnostics facilities in countries such as China, India, Japan, and South Korea. Meanwhile, emerging markets in Latin America, the Middle East, and Africa are gradually gaining traction, fueled by increased healthcare spending, growing adoption of advanced diagnostic technologies, and heightened recognition of genomics-based personalized care. For instance, according to a 2025 OECD report, global spending on genomics and precision medicine exceeded $25billion, with North America accounting for nearly 45% of the total, Europe contributing 30%, and Asia Pacific representing 20%, reflecting the shifting investments and rapid uptake of advanced genomic testing across regions.
United States Pan-genomic and Multi-gene Panel Testing Market – Country Insights
The U.S. pan-genomic and multi-gene panel testing market is experiencing steady growth, driven by a well-established healthcare infrastructure, advanced molecular diagnostic capabilities, and strong emphasis on precision medicine. Key market players, including Invitae Corporation, Myriad Genetics, Guardant Health, Tempus Labs, Ambry Genetics, Foundation Medicine, Caris Life Sciences, GeneDx, Natera, Fulgent Genetics, PathAI, NeoGenomics, Counsyl, BioReference Laboratories, and ArcherDX, offer comprehensive genetic testing solutions targeting oncology, hereditary disorders, and rare diseases. These companies focus on expanding access to multi-gene panels, improving diagnostic accuracy, and supporting personalized treatment strategies for patients across the United States.
According to the U.S. National Institutes of Health (NIH) and the Centers for Medicare & Medicaid Services (CMS), the country’s genetic testing and molecular diagnostics sector is growing rapidly, fueled by rising demand for pan-genomic and multi-gene panel tests in oncology, rare diseases, and hereditary conditions. Government initiatives such as Medicare coverage for genomic testing, the Precision Medicine Initiative, and NIH-funded genomic research programs are further encouraging the adoption of clinically validated, comprehensive multi-gene testing. These measures are expanding patient access to advanced diagnostics and reinforcing the implementation of precision medicine nationwide.
Globally, investment in genomic testing is also increasing. For example, the OECD reported in 2025 that worldwide spending on genomics and precision medicine surpassed $25billion, with the United States accounting for nearly 45%, Europe about 30%, and Asia Pacific roughly 20%. These figures highlight not only the U.S. leadership in genomic testing but also the rising adoption of pan-genomic and multi-gene panel testing in other regions, reflecting growing global interest in precision medicine and personalized healthcare.
Pan-genomic And Multi-gene Panel Testing Market- Competitive Landscape:
The pan-genomic and multi-gene panel testing market is moderately concentrated, with several leading companies driving innovation in genetic diagnostics and precision medicine. Prominent players include Invitae Corporation, Myriad Genetics, Guardant Health, Tempus Labs, Ambry Genetics, Foundation Medicine, Caris Life Sciences, GeneDx, Natera, Fulgent Genetics, PathAI, NeoGenomics, Counsyl, BioReference Laboratories, and ArcherDX. These companies compete by offering comprehensive genetic testing solutions, including multi-gene panels for oncology, hereditary disorders, and rare diseases, as well as services for pharmacogenomics and personalized therapeutics.
For instance, in 2024, Guardant Health launched a liquid biopsy multi-gene panel enabling non-invasive tumor profiling and real-time monitoring of treatment responses. Market competition is fueled by rising demand for rapid, accurate, and clinically actionable genomic insights that support personalized treatment decisions. Companies are also expanding their offerings to include whole-genome sequencing, targeted gene panels, companion diagnostics, and advanced bioinformatics tools to meet the evolving needs of clinicians, researchers, and patients in precision medicine.
Recent Developments:
- In July 2025, QIAGEN introduced its QIAseq xHYB Long Read Panels, a suite of target-enrichment assays designed for long-read sequencing platforms such as PacBio. These panels enable high-resolution analysis of complex genomic regions, including structural variants, repeat expansions, and HLA loci, using native long-read technology. The portfolio includes fixed panels for applications such as hereditary cancer and HLA typing, along with customizable options integrated with QIAGEN’s sample preparation and bioinformatics workflow.
- In April 2025, Baylor Genetics launched an advanced RNA sequencing test aimed at improving the detection of specific genetic variants. The test combines curated genomic data, expert interpretation, and an AI-powered predictive algorithm, complementing existing Whole Exome and Whole Genome Sequencing (WES/WGS) methods. This innovation allows for the reclassification of variants, supporting faster, more precise, and clinically actionable diagnostic and treatment decisions.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL PAN-GENOMIC AND MULTI-GENE PANEL TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Invitae Corporation
- Myriad Genetics
- Guardant Health
- Tempus Labs
- Ambry Genetics
- Foundation Medicine
- Caris Life Sciences
- GeneDx
- Natera
- Fulgent Genetics
- PathAI
- NeoGenomics
- Counsyl
- BioReference Laboratories
- ArcherDX
GLOBAL PAN-GENOMIC AND MULTI-GENE PANEL TESTING MARKET, BY TEST- MARKET ANALYSIS, 2019 - 2032
- Oncology Multi-Gene Panels
- Pan-Genomic / Whole Exome Based Panels
- Pharmacogenomics (PGx) Panels
- Comprehensive Hereditary Disease Panels
GLOBAL PAN-GENOMIC AND MULTI-GENE PANEL TESTING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Neurology and Neurogenetics
- Oncology
- Reproductive Carrier Screening
- Cardiology & Cardiomyopathy
- Newborn & Pediatric Genomics
- Rare & Undiagnosed Genetic Diseases
GLOBAL PAN-GENOMIC AND MULTI-GENE PANEL TESTING MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032
- Specialty Genomic Centers
- Independent Diagnostic Labs
- Hospital-based Genetic Labs
- Others
GLOBAL PAN-GENOMIC AND MULTI-GENE PANEL TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Pan-genomic And Multi-gene Panel Testing Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Pan-genomic And Multi-gene Panel Testing Market Snippet by Test
2.1.2. Pan-genomic And Multi-gene Panel Testing Market Snippet by Application
2.1.3. Pan-genomic And Multi-gene Panel Testing Market Snippet by End-Use
2.1.4. Pan-genomic And Multi-gene Panel Testing Market Snippet by Country
2.1.5. Pan-genomic And Multi-gene Panel Testing Market Snippet by Region
2.2. Competitive Insights
3. Pan-genomic And Multi-gene Panel Testing Key Market Trends
3.1. Pan-genomic And Multi-gene Panel Testing Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Pan-genomic And Multi-gene Panel Testing Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Pan-genomic And Multi-gene Panel Testing Market Opportunities
3.4. Pan-genomic And Multi-gene Panel Testing Market Future Trends
4. Pan-genomic And Multi-gene Panel Testing Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Pan-genomic And Multi-gene Panel Testing Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Pan-genomic And Multi-gene Panel Testing Market Landscape
6.1. Pan-genomic And Multi-gene Panel Testing Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Pan-genomic And Multi-gene Panel Testing Market – By Test
7.1. Overview
7.1.1. Segment Share Analysis, By Test, 2024 & 2032 (%)
7.1.2. Oncology Multi-Gene Panels
7.1.3. Pan-Genomic / Whole Exome Based Panels
7.1.4. Pharmacogenomics (PGx) Panels
7.1.5. Comprehensive Hereditary Disease Panels
8. Pan-genomic And Multi-gene Panel Testing Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
8.1.2. Neurology and Neurogenetics
8.1.3. Oncology
8.1.4. Reproductive Carrier Screening
8.1.5. Cardiology & Cardiomyopathy
8.1.6. Newborn & Pediatric Genomics
8.1.7. Rare & Undiagnosed Genetic Diseases
9. Pan-genomic And Multi-gene Panel Testing Market – By End-Use
9.1. Overview
9.1.1. Segment Share Analysis, By End-Use, 2024 & 2032 (%)
9.1.2. Specialty Genomic Centers
9.1.3. Independent Diagnostic Labs
9.1.4. Hospital-based Genetic Labs
9.1.5. Others
10. Pan-genomic And Multi-gene Panel Testing Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Pan-genomic And Multi-gene Panel Testing Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Pan-genomic And Multi-gene Panel Testing Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. UK Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.8.5. UK Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. France Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.9.5. France Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. Italy Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.10.5. Italy Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.3. Spain Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.11.5. Spain Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.3. The Netherlands Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.12.5. The Netherlands Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.13.5. Sweden Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.3. Russia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.14.5. Russia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.15.5. Poland Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.3.16. Rest of Europe
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.16.3. Rest of the Europe Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.16.5. Rest of the Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Pan-genomic And Multi-gene Panel Testing Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. APAC Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.6. APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. China Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.7.5. China Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. India Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.8.5. India Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Indonesia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.12.5. Indonesia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Thailand Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.13.5. Thailand Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. Pan-genomic And Multi-gene Panel Testing Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. LATAM Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.6. LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. Pan-genomic And Multi-gene Panel Testing Key Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. MEA Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.6. MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. UAE Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.8.5. UAE Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Pan-genomic And Multi-gene Panel Testing Industry
11.1. Competitive Benchmarking
11.1.1. Competitive Dashboard
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. Invitae Corporation
11.2.2. Myriad Genetics
11.2.3. Guardant Health
11.2.4. Tempus Labs
11.2.5. Ambry Genetics
11.2.6. Foundation Medicine
11.2.7. Caris Life Sciences
11.2.8. GeneDx
11.2.9. Natera
11.2.10. Fulgent Genetics
11.2.11. PathAI
11.2.12. NeoGenomics
11.2.13. Counsyl
11.2.14. BioReference Laboratories
11.2.15. ArcherDXOthers
12. 360 Degree AnalystView
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL PAN-GENOMIC AND MULTI-GENE PANEL TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Invitae Corporation
- Myriad Genetics
- Guardant Health
- Tempus Labs
- Ambry Genetics
- Foundation Medicine
- Caris Life Sciences
- GeneDx
- Natera
- Fulgent Genetics
- PathAI
- NeoGenomics
- Counsyl
- BioReference Laboratories
- ArcherDX
GLOBAL PAN-GENOMIC AND MULTI-GENE PANEL TESTING MARKET, BY TEST- MARKET ANALYSIS, 2019 - 2032
- Oncology Multi-Gene Panels
- Pan-Genomic / Whole Exome Based Panels
- Pharmacogenomics (PGx) Panels
- Comprehensive Hereditary Disease Panels
GLOBAL PAN-GENOMIC AND MULTI-GENE PANEL TESTING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Neurology and Neurogenetics
- Oncology
- Reproductive Carrier Screening
- Cardiology & Cardiomyopathy
- Newborn & Pediatric Genomics
- Rare & Undiagnosed Genetic Diseases
GLOBAL PAN-GENOMIC AND MULTI-GENE PANEL TESTING MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032
- Specialty Genomic Centers
- Independent Diagnostic Labs
- Hospital-based Genetic Labs
- Others
GLOBAL PAN-GENOMIC AND MULTI-GENE PANEL TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
